Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10616
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJohnston, Colin Ien
dc.contributor.authorMooser, Ven
dc.contributor.authorSun, Yen
dc.contributor.authorFabris, Brunoen
dc.date.accessioned2015-05-16T00:07:49Z
dc.date.available2015-05-16T00:07:49Z
dc.date.issued1991-02-01en
dc.identifier.citationClinical and Experimental Pharmacology & Physiology; 18(2): 107-10en
dc.identifier.govdoc1850674en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10616en
dc.description.abstract1. Cardiac angiotensin-converting enzyme (ACE) is localized in high concentration in cardiac valves, coronary vessels, right and left atrium and right and left ventricle. 2. Cardiac ACE is functionally active in converting angiotension I to angiotensin II. 3. The level of cardiac ACE measured by radioinhibitor binding or by quantitative in vitro autoradiography was greatly increased after experimental myocardial infarction in the rat. The increase was greatest in the fibrous scar tissue of the free left ventricular wall infarct, but there were also significant increases in the ACE concentration in the four chambers of the heart. 4. Treatment with enalapril for 4 weeks following coronary ligation inhibited cardiac ACE, including the high levels found in the scar in the left ventricular free wall. 5. There was a close relationship between the systolic blood pressure and left ventricular mass in several models of experimental hypertension, despite varying degrees of activation of the renin-angiotensin system. However no relationship between the degree of left ventricular hypertrophy and changes in cardiac ACE could be determined. 6. Inhibition of cardiac ACE may contribute to the beneficial effect of ACE inhibitors in cardiac hypertrophy and remodelling, and may play a part in the cardioprotective role of ACE inhibitor.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherAutoradiographyen
dc.subject.otherBinding Sitesen
dc.subject.otherCardiomegaly.enzymology.etiologyen
dc.subject.otherHypertension.complications.enzymologyen
dc.subject.otherMyocardial Infarction.enzymologyen
dc.subject.otherPeptidyl-Dipeptidase A.metabolismen
dc.subject.otherRadioligand Assayen
dc.subject.otherRatsen
dc.subject.otherRats, Inbred Strainsen
dc.titleChanges in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical and Experimental Pharmacology & Physiologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pages107-10en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/1850674en
dc.type.austinJournal Articleen
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Jan 14, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.